Nurix

Director, Pharmaceutical Development

Nurix • $218K — $260K *
Brisbane, CA 94005In-Person
Pharmaceuticals & Biotech
11 - 15 years of experience
Today
Be an Early Applicant
Job Overview by Ladders

Qualifications

  • Ph.D. in Pharmaceutical Sciences or related field preferred with 12 years of industry experience.
  • 12+ years of progressive experience in pharmaceutical development within biotechnology, pharmaceutical, or CDMO sectors.
  • Deep expertise in oral and topical small molecule development, particularly in enabled formulations.
  • Comprehensive hands-on experience with QbD methodologies, including risk assessments and control strategy establishment.
  • Significant experience in late-stage development (Phase 2b/3 and regulatory submissions).
  • Proven track record with CMC regulatory submissions (INDs, NDAs, CTDs) and agency communications.
  • Direct experience managing CDMO relationships and project governance.

Responsibilities

  • Lead QbD-based formulation and development for oral and topical dosage forms across all phases.
  • Define QTPP and critical attributes to guide formulation strategy effectively.
  • Conduct risk assessments to identify and manage material and process attributes.
  • Develop and optimize scalable manufacturing processes for dosage forms.
  • Oversee manufacturing scale-up from lab to commercial scale and troubleshoot process issues.
  • Drive late-stage development activities, including clinical supply and process verification.
  • Manage CDMO partnerships and act as a technical liaison with cross-functional teams.

Benefits

  • Mentorship and development opportunities for scientific talent.
  • Collaborative and team-oriented culture promoting diverse viewpoints.
  • Hands-on approach with a focus on innovative solutions.
Full Job Description
Title: Director, Pharmaceutical Development



Position

Nurix Therapeutics, Inc. is seeking a highly experienced Director of Pharmaceutical Development. The role leads small molecule drug product development focused on oral and topical dosage forms. Responsibilities span QbD-based formulation and process development from early phase through commercial launch. The position requires strong cross-functional collaboration and hands-on CDMO management. This position is on site in the Brisbane, CA office.

Responsibilities

Formulation & Process Development
  • Lead QbD-based formulation and process development for small molecule drug programs with a focus on oral and topical dosage forms across all development phases.
  • Apply expertise in BCS Class II/IV compound development and enabling formulation technologies, including amorphous solid dispersions (spray-dried dispersions, hot-melt extrusion), lipid-based drug delivery systems (SMEDDS, SEDDS, lipid suspensions), and nano-formulations to address solubility and bioavailability challenges.
  • Define and document the Quality Target Product Profile (QTPP) and identify Critical Quality Attributes (CQAs) to guide formulation strategy.
  • Conduct systematic risk assessments to identify Critical Material Attributes (CMAs) and Critical Process Parameters (CPPs) using FMEA and other risk assessment tools.
  • Develop and optimize manufacturing processes appropriate to the dosage form, ensuring scalability and process robustness.

Scale-Up & Technology Transfer
  • Lead manufacturing scale-up activities from laboratory to pilot and commercial scale, ensuring robust and reproducible processes.
  • Troubleshoot manufacturing deviations, out-of-specification results, and process failures; drive root cause analysis and implement corrective actions.

Late-Stage Development & Regulatory
  • Drive late-stage development activities (Phase 2b through commercial launch) including clinical supply manufacturing, process performance qualification (PPQ), and continued process verification (CPV).
  • Author and review CMC sections of regulatory submissions including INDs, NDAs, and MAAs.
  • Ensure all development activities comply with current GMP regulations and internal quality standards.

CDMO Management & Cross-Functional Leadership
  • Manage external CDMO partnerships, including vendor qualification, technical oversight, and performance governance to ensure project timelines, quality standards, and budget commitments are met.
  • Serve as the primary technical point of contact between pharmaceutical development and cross-functional teams including Analytical Development, Clinical Operations, Regulatory Affairs, Quality, Supply Chain, and Commercial.
  • Provide scientific leadership and mentorship to junior scientists, associates, and project team members.

Requirements
  • Ph.D. in Pharmaceutical Sciences, Pharmaceutics, Chemical Engineering, Chemistry, or a closely related discipline strongly preferred with 12 years of industry experience.
  • 12+ years of progressive pharmaceutical development experience in an industry setting (biotechnology, pharmaceutical, or CDMO).
  • Deep expertise in small molecule drug product development with a focus on oral and topical dosage forms, especially enabled formulation development (e.g., amorphous solid dispersions, lipid-based systems, nano-formulations).
  • Comprehensive hands-on experience with QbD methodologies: QTPP definition, CQA identification, CMA/CPP risk assessment, DoE, design space development, and control strategy establishment.
  • Significant late-stage development experience (Phase 2b/3 and NDA/MAA submission) is required.
  • Proven track record of authoring and/or reviewing CMC regulatory submissions (INDs, NDAs, CTDs) and successfully responding to agency queries.
  • Direct CDMO management experience, including technical oversight, project governance, and relationship management.
  • Knowledge of lifecycle management, post-approval changes, and SUPAC guidance.
  • For the Director level: demonstrated people management experience leading a team of scientists/managers, department-level strategic planning, and budget/resource ownership across multiple concurrent programs.
  • Primarily office and laboratory environment; occasional GMP manufacturing facility access required.
  • Approximately 25% travel required, including domestic and international trips to CDMO sites, clinical manufacturing sites, regulatory agency meetings, and scientific conferences.
  • Must be able to gown for cleanroom/GMP environments

Core Competencies
  • Scientific Leadership - Recognized internal and external thought leader in pharmaceutical development; drives scientific innovation and excellence.
  • Strategic Thinking - Ability to anticipate technical and regulatory risks and develop proactive mitigation strategies that protect project timelines.
  • Cross-Functional Collaboration - Demonstrated ability to build strong working relationships and influence without authority across diverse internal and external stakeholders.
  • Project Management - Experienced in managing multiple complex projects simultaneously in a fast-paced, deadline-driven environment.
  • Communication - Exceptional written and verbal communication skills; able to present complex scientific data clearly to both technical and non-technical audiences, including senior leadership and regulatory agencies.
  • People Development - Commitment to mentoring and developing scientific talent within the organization.

Salary Range: 218K - 260K plus bonus and equity.

Fit with Nurix Culture and Values
  • Strong team orientation; highly collaborative
  • Solutions and results-oriented focus
  • Hands-on approach; resourceful and open to diverse points of view

Application Process

About Nurix

Nurix Therapeutics is a biotechnology company that is focused on the discovery, development, and commercialization of small molecule therapies that modulate the ubiquitin proteasome system (UPS) for the treatment of cancer and other diseases. The company's proprietary drug discovery platform is based on the use of DNA-encoded libraries (DELs) to identify small molecules that selectively bind to E3 ligases, which are key enzymes in the UPS. Nurix's lead drug candidate, NX-2127, is a first-in-class small molecule inhibitor of the CBL-B E3 ligase that is being developed for the treatment of solid tumors and hematological malignancies. The company was founded in 2013 and is headquartered in San Francisco, California.
Learn more about Nurix
Size
135 employees
Market Cap
$486 million
Industry
Pharmaceuticals & Biotech
Net Income
-$43.2 million
Founded
2009
Revenue
$17.8 million
NASDAQ
NRIX
* Ladders Estimates

Similar Jobs

Ad banner background

Get Ready For Your
Next Interview

More Jobs at Nurix

More Pharmaceuticals & Biotech Jobs

Find similar Director, Pharmaceutical Development jobs:

NationwideBrisbane, CA